David A. Pérez-Martínez

944 total citations
43 papers, 658 citations indexed

About

David A. Pérez-Martínez is a scholar working on Neurology, Psychiatry and Mental health and Physiology. According to data from OpenAlex, David A. Pérez-Martínez has authored 43 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 13 papers in Psychiatry and Mental health and 12 papers in Physiology. Recurrent topics in David A. Pérez-Martínez's work include Alzheimer's disease research and treatments (10 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Neurological disorders and treatments (7 papers). David A. Pérez-Martínez is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Neurological disorders and treatments (7 papers). David A. Pérez-Martínez collaborates with scholars based in Spain, United States and United Kingdom. David A. Pérez-Martínez's co-authors include Alberto Villarejo‐Galende, Alejandro Rodríguez‐Molinero, Carlos Pérez‐López, Marta González‐Sánchez, Sara Llamas‐Velasco, Andreu Catalá, Albert Samà, Alejandro Herrero-San Martín, Daniel Rodríguez-Martín and Joan Cabestany and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Journal of Neuroinflammation.

In The Last Decade

David A. Pérez-Martínez

39 papers receiving 644 citations

Peers

Countries citing papers authored by David A. Pérez-Martínez

Since Specialization

Citations

This map shows the geographic impact of David A. Pérez-Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Pérez-Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Pérez-Martínez more than expected).

Fields of papers citing papers by David A. Pérez-Martínez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Pérez-Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Pérez-Martínez. The network helps show where David A. Pérez-Martínez may publish in the future.

Co-authorship network of co-authors of David A. Pérez-Martínez

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Pérez-Martínez. A scholar is included among the top collaborators of David A. Pérez-Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Pérez-Martínez. David A. Pérez-Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sex-specific metabolic effects of Treg expansion in db/db mice 2025 ·Frontiers in Immunology ·David A. Pérez-Martínez, (unknown), (unknown), Anna Álvarez-Guaita, (unknown), Cristina Hernández, Rafael Simó, María Llorián‐Salvador	0
2	Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress 2025 ·Translational Psychiatry ·(unknown), Igor Horrillo, (unknown), David A. Pérez-Martínez, Guadalupe Rivero, Amaia M. Erdozain, J. Javier Meana, Jorge E. Ortega	1
3	Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study 2025 ·Molecular Neurodegeneration ·(unknown), Yuetiva Deming, (unknown), Sterling C. Johnson, Sanjay Asthana, Gwendlyn Kollmorgen, (unknown), Cynthia M. Carlsson, Ozioma C. Okonkwo, David A. Pérez-Martínez, Alberto Villarejo‐Galende, Kaj Blennow, Marc Suárez‐Calvet, Henrik Zetterberg, Barbara B. Bendlin, Estrella Morenas‐Rodríguez	1
4	Comparison of clinical measures of motor function with a Holter monitor in Parkinson’s disease 2025 ·Clinical Parkinsonism & Related Disorders ·Carlos Pérez‐López, Núria Caballol, Maríateresa Buongiorno, María A. Ávila Rivera, Núria López Ariztegui, Lydia López Manzanares, Jorge Hernández‐Vara, (unknown), (unknown), María Álvarez Saúco, (unknown), David A. Pérez-Martínez, (unknown), (unknown), (unknown), (unknown), Juan Carlos Martínez‐Castrillo, Alejandro Rodríguez‐Molinero	1
5	Proposal for Responsible Use of Generative Artificial Intelligence in Medical Practice 2025 ·Revista de Neurología ·David A. Pérez-Martínez	0
6	Regulatory T cell expansion prevents retinal degeneration in type 2 diabetes 2024 ·Journal of Neuroinflammation ·María Llorián‐Salvador, David A. Pérez-Martínez, Miao Tang, Anna Duarri, Marta García‐Ramírez, (unknown), (unknown), (unknown), Patricia Bogdanov, Jose A. Gomez‐Sanchez, Alan W. Stitt, Cristina Hernández, Alerie Guzman de la Fuente, Rafael Simó	5
7	Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease 2023 ·Neurology and Therapy ·Gustavo Saposnik, (unknown), (unknown), Emilio Franco‐Macías, (unknown), (unknown), Ricardo Allegri, David A. Pérez-Martínez, Jorge Mauriño	2
8	Cerebral amyloid angiopathy–related inflammation: clinical features and treatment response in a case series 2023 ·Neurología (English Edition) ·(unknown), (unknown), Sara Llamas‐Velasco, (unknown), Marta González‐Sánchez, (unknown), (unknown), (unknown), (unknown), Amaya Hilario, A. Ramos, (unknown), Óscar Toldos, Aurelio Hernández‐Laín, David A. Pérez-Martínez, Alberto Villarejo‐Galende	2
9	Does Your Loved One With Cognitive Symptoms Need to See a Doctor? Check It Online 2022 ·Frontiers in Computational Neuroscience ·Luis Agüera-Ortíz, Manuel Martín‐Carrasco, (unknown), Pablo Martínez‐Lage, David A. Pérez-Martínez, (unknown), (unknown), Guillermo García‐Ribas	1
10	Inflamación relacionada con angiopatía amiloide: características clínicas y respuesta al tratamiento en una serie de casos 2021 ·Neurología ·(unknown), (unknown), Sara Llamas‐Velasco, (unknown), Marta González‐Sánchez, (unknown), (unknown), (unknown), (unknown), Amaya Hilario, A. Ramos, (unknown), Óscar Toldos, Aurelio Hernández‐Laín, David A. Pérez-Martínez, Alberto Villarejo‐Galende	3
11	Multicentre, randomised, single-blind, parallel group trial to compare the effectiveness of a Holter for Parkinson’s symptoms against other clinical monitoring methods: study protocol 2021 ·BMJ Open ·Alejandro Rodríguez‐Molinero, Jorge Hernández‐Vara, Antonio Miñarro, Carlos Pérez‐López, (unknown), Juan Carlos Martínez‐Castrillo, David A. Pérez-Martínez	7
12	A Kinematic Sensor and Algorithm to Detect Motor Fluctuations in Parkinson Disease: Validation Study Under Real Conditions of Use 2018 ·JMIR Rehabilitation and Assistive Technologies ·Alejandro Rodríguez‐Molinero, Carlos Pérez‐López, Albert Samà, Eva de Mingo-Fernández, Daniel Rodríguez-Martín, Jorge Hernández‐Vara, Àngels Bayés, (unknown), Ramiro Álvarez, David A. Pérez-Martínez, Andreu Catalá	45
13	Amyloid pet in primary progressive aphasia: case series and systematic review of the literature 2016 ·Journal of Neurology ·Alberto Villarejo‐Galende, Sara Llamas‐Velasco, Adolfo Gómez‐Grande, Verónica Puertas‐Martín, Israel Contador, (unknown), Marta González‐Sánchez, Rocío Trincado, (unknown), (unknown), David A. Pérez-Martínez, Alejandro Herrero-San Martín	21
14	A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease 2015 ·Journal of Alzheimer s Disease ·Javier Olazarán, Luis Gil‐de‐Gómez, (unknown), Meritxell Valentí, Belén Frades‐Payo, Juan Marín-Muñoz, Carmen Antúnez, Ana Frank, (unknown), (unknown), (unknown), M.C. Guisasola, Félix Bermejo‐Pareja, Álvaro Sánchez‐Ferro, David A. Pérez-Martínez, (unknown), (unknown), Alberto Rábano, Miguel Calero	89
15	Validation of a Portable Device for Mapping Motor and Gait Disturbances in Parkinson’s Disease 2015 ·JMIR mhealth and uhealth ·Alejandro Rodríguez‐Molinero, Albert Samà, David A. Pérez-Martínez, Carlos Pérez‐López, (unknown), Àngels Bayés, Pilar Sánz, Matilde Calopa, César Gálvez‐Barrón, Eva de Mingo-Fernández, Daniel Martín, (unknown), Françesc Formiga, Joan Cabestany, Andreu Catalá	44
16	Aplicación práctica de los test cognitivos breves 2015 ·Neurología ·Javier Olazarán, (unknown), Teodoro del Ser, (unknown), Josep L. Conde‐Sala, Félix Bermejo‐Pareja, Secundino López‐Pousa, David A. Pérez-Martínez, Alberto Villarejo‐Galende, (unknown), Elena Navarro González, (unknown), Jordi Peña‐Casanova, Cristóbal Carnero Pardo	49
17	Estudio piloto de un nuevo método de estimulación aritmética empleando el ábaco en ancianos sanos y con trastorno cognitivo 2015 ·Neurología ·Jordi A. Matías‐Guiu, (unknown), David A. Pérez-Martínez, Jorge Matías‐Guiu	9
18	Dyskinesia and motor state detection in Parkinson's Disease patients with a single movement sensor 2012 ·PubMed ·Albert Samà, Carlos Pérez‐López, (unknown), Daniel Rodríguez-Martín, Andreu Catalá, Joan Cabestany, David A. Pérez-Martínez, Alejandro Rodríguez‐Molinero	57
19	Treatment of Parkinson’s disease could be regulated by movement sensors: Subcutaneous infusion of varying apomorphine doses according to the intensity of motor activity 2009 ·Medical Hypotheses ·Alejandro Rodríguez‐Molinero, David A. Pérez-Martínez, Andreu Catalá, Joan Cabestany, (unknown)	5
20	Conferencia de consenso sobre tiempos de visita en Neurología: recomendaciones sobre tiempos de visita para la asistencia neurológica ambulatoria en España 2001 ·Neurología ·Ana Camacho, David A. Pérez-Martínez, Alberto Villarejo‐Galende, (unknown), (unknown), Pilar de la Peña, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact